NCT06171100View on ClinicalTrials.gov

Low-dose Tolvaptan for Inpatient Hyponatraemia.

RecruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

December 30, 2024

Conditions
HyponatremiaSIADH
Interventions
DRUG

Tolvaptan

"Oral ingestion of low dose Tolvaptan (7.5mg daily) for management of inpatient hyponatraemia for 1st dose Tolvaptan group.~Oral ingestion of low dose Tolvaptan (7.5mg daily) or standard dose Tolvaptan (15mg daily) for 2nd dose Tolvaptan group."

Trial Locations (1)

Unknown

RECRUITING

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER